Fundamentals

Digital Informed Consent: What Changes and What Does Not

By Daniel Sardá · Published on October 22, 2026

7 min read1,332 words

Digitalizing consent can make information and recordkeeping easier, but it does not replace understanding, questions, or a free decision.

A signed form is not enough to show that someone understood a medical intervention and freely chose to accept it. That is true on paper and on a screen. Digital informed consent is not an isolated click, a PDF, or an electronic signature. It is a process of communication and decision-making that uses digital tools to provide information, allow questions, express a choice, and document it.

Technology can improve that process. A platform can present videos, adjust text size, let a patient proceed at their own pace, and retain the exact version they read. It can also turn an already deficient formality into a faster sequence of boxes that nobody understands. The difference is not whether the medium is modern, but whether it protects the person's autonomy.

What it means to give informed consent

In a clinical setting, consent means that a person with decision-making capacity receives relevant information about an intervention, understands its essential aspects, has an opportunity to ask questions, and chooses without coercion whether to accept it, refuse it, or consider alternatives. The conversation and the decision should be documented.

Relevant information commonly includes the nature and purpose of the intervention, its foreseeable risks and benefits, reasonable alternatives, and, where appropriate, the option of declining treatment. The American Medical Association's Code of Medical Ethics presents these as elements of a professional process, not as a magical property of a form.

The underlying principle is straightforward: decisions about one's own body belong first and foremost to the person affected. That authority requires understandable information and genuine freedom to decide. For that reason, genuinely voluntary consent cannot be reduced to collecting a mark that administratively protects the provider.

Key idea: A signature documents a decision; on its own, it does not demonstrate understanding, capacity, or the absence of pressure.

What changes when the process is digital

Digital tools change the means available, not the essential obligations. Information can be provided through text, audio, video, illustrations, or interactive questions. A patient can review an explanation at home, pause it, go back, and keep a copy. The system can also record which version was displayed, when it was accepted, and which steps were completed.

These functions can support understanding and traceability. Systematic reviews of digital consent tools have found comprehension outcomes comparable to, and in some studies better than, those associated with paper. The evidence is heterogeneous, however: it does not support the conclusion that every platform is superior. Content, interface, context, and support still matter.

Joint OHRP and FDA guidance on electronic informed consent stresses that there must be a way to ask questions and that the responsible party does not disappear behind the system. The guidance concerns primarily regulated research in the United States; it is useful as a design reference, not as a universal clinical rule.

Consider two cases. In the first, a person receives a lengthy PDF by email, is asked to sign it immediately, and has no one to answer their questions. In the second, a platform explains the intervention in stages, shows alternatives, allows the person to pause, offers contact with a professional, and provides a copy. Both processes are digital, but only the second creates better conditions for an informed decision.

Clinical consent is not consent to use data

Agreeing to a medical intervention does not mean authorizing every use of health information. These are separate decisions.

Clinical consent concerns what may be done to the body or in connection with care. Data protection addresses different questions: what information is collected, why it is used, who it is shared with, how long it is retained, and what legal basis applies. The UK's data protection authority, for example, notes that medical consent is separate from the lawful basis for processing data.

Clinical consent should not be confused with a platform's terms of use or cookie consent, either. They may appear in the same interface, but they do not authorize the same things and need not follow the same rules. Protecting digital privacy requires keeping those choices distinguishable.

Key idea: Agreeing to treatment is not the same as agreeing to advertising, research, third-party sharing, or indefinite retention of clinical data.

How to recognize a trustworthy digital process

No checklist can guarantee validity across all countries and procedures. There are, however, practical signs that help assess the quality of a process:

• Specific, understandable information. It should explain the intervention, its benefits, risks, and alternatives in language appropriate for the patient.
• A genuine opportunity to ask questions. A decorative contact channel, or one that never responds, does not serve that purpose.
• Affirmative action. The decision should be expressed clearly, with no pre-checked boxes or ambiguity about what is being accepted.
• Proportionate identification. The method should provide reasonable confidence about who is deciding without collecting more data than necessary.
• Integrity and version control. It should be possible to know what content was presented and to detect later changes.
• An accessible record and copy. The person should be able to keep or retrieve the information and a record of their decision.
• Appropriate stewardship. Records contain sensitive information; access to them and their retention require limits and protection.
• A way to reconsider. Where appropriate, the system should explain how to withdraw consent or communicate a change of decision, without promising that medical acts already performed can be undone.

The categories of electronic, advanced, digital, or qualified signature vary by jurisdiction. The European eIDAS Regulation, for example, links certain signature levels to identifying the signer and detecting changes. It illustrates how technology can strengthen authorship and integrity; it is not universal proof that a person understood what was explained.

Possible benefits and real barriers

A well-designed system can reduce distance, make materials available in different formats, and improve recordkeeping. For some people, reading calmly outside the clinic reduces pressure and makes it easier to speak with family members or seek a second opinion.

But the same solution can exclude someone without reliable connectivity, someone who shares a device, someone with little digital experience, or someone who needs accessibility support. Research on digital consent tools identifies these barriers as well. A video without captions, text that does not work with a screen reader, or a session that expires too quickly can prevent an informed decision. Privacy at home should not be assumed either: it is not always possible to read or speak without someone else watching or applying pressure.

Digitalization therefore should not mean removing every human or non-digital alternative. Assistance, reasonable accommodation, and the option to continue by another route are part of a respectful design.

Key idea: More records can improve traceability, but they also increase the volume of sensitive data that must be protected.

Questions to ask before agreeing

Before confirming an intervention online, it is worth checking:

• Do I understand what is proposed, its purpose, and the alternatives?
• Can I ask questions and receive an answer from a responsible person?
• Do I know exactly what I am agreeing to, and which data permissions are separate?
• Can I download or retrieve a copy, including the version I reviewed?
• Is there an accessible option if I cannot use the platform?
• Am I told how to communicate a change of decision and what its limits would be?

These questions do not replace medical advice or determine legal validity. Requirements concerning capacity, minors, witnesses, identification, record retention, telemedicine, or high-risk interventions depend on the country and the context.

The central standard remains the same: technology should serve personal decision-making. A trustworthy digital process does not aim to obtain a signature as quickly as possible; it creates the conditions for someone to understand, ask questions, and choose. When those conditions are absent, a screen can record an action, but it cannot manufacture informed consent.